GlassScriptPhysician profile
Pawan K Singh
NPI 1588003131
$7,421.42
in general payments reported to CMS, 2019-2025
34 companies · $832 in 2025
The $832 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $860 · 2020: $405 · 2021: $288 · 2022: $2,035 · 2023: $2,594 · 2024: $407 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,686 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,685.85 |
| Education | $147.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $2,809.98 | 2019-2025 | Optune Gio, Optune |
| Abbvie INC. | $785.26 | 2021-2024 | Ubrelvy, Qulipta, Botox |
| Sk Life Science, INC. | $592.82 | 2022-2023 | Xcopri |
| Sumitomo Pharma America, INC. | $434.23 | 2023 | Aptiom |
| Teva Pharmaceuticals USA, INC. | $404.58 | 2022-2023 | Austedo Xr, Austedo, Ajovy |
| Neurocrine Biosciences, INC. | $190.88 | 2022-2023 | Ingrezza, Ongentys |
| Ucb, INC. | $190.38 | 2022-2023 | Briviact |
| Pfizer INC. | $160.22 | 2023 | |
| Monteris Medical Corporation | $155.78 | 2020-2022 | |
| Eisai INC. | $149.90 | 2023 | |
| Argenx US, INC. | $147.54 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $138.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $135.54 | 2021-2025 | Wainua |
| Biohaven Pharmaceutical Holding Company LTD. | $127.92 | 2022 | |
| Telix Pharmaceuticals | $118.93 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $111.60 | 2023 | |
| Servier Pharmaceuticals LLC | $99.75 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $97.65 | 2022 | |
| Celgene Corporation | $87.37 | 2022 | |
| Sunovion Pharmaceuticals INC. | $58.88 | 2022 | |
| Biogen, INC. | $57.54 | 2021-2022 | |
| Octapharma USA, INC. | $55.14 | 2023 | Panzyga |
| Btg International INC. | $50.10 | 2025 | Voraxaze |
| Novartis Pharmaceuticals Corporation | $41.83 | 2021 | |
| Avanir Pharmaceuticals, INC. | $30.88 | 2022 | |
| Alexion Pharmaceuticals, INC. | $29.91 | 2022 | |
| Kyowa Kirin, INC. | $29.47 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $28.64 | 2023 | Rexulti |
| Lilly USA, LLC | $23.83 | 2023 | Amyvid |
| Avion Pharmaceuticals | $23.45 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.01 | 2021 | |
| Allergan, INC. | $15.19 | 2021 | |
| Lundbeck LLC | $14.76 | 2023 | Rexulti |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pawan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.